| Type | Herb / Botanical |
| Active Cmpd | Rosmarinic acid, Citral, Triterpenes |
| Source | Melissa officinalis L. |
| Dose Range | 300–1,600 mg (extract) |
| Half-life | ~1–2 hours (Rosmarinic acid) |
| Main Benefit | Anxiolysis, Sleep support, Lipid management |
| Absorption | Rapid; peaks in 1–3 hours |
Lemon Balm (Melissa officinalis) is a lemon-scented perennial herb in the mint family with robust clinical evidence for reducing acute anxiety, improving sleep quality, and managing metabolic health markers. Unlike many sedatives, moderate doses of Lemon Balm uniquely promote a state of "calm focus" by balancing GABAergic inhibition with cholinergic cognitive support.
Aliases
Key points (high-level summary)
What people use it for
Lemon Balm is a fragrant herb native to south-central Europe, the Mediterranean, and Central Asia, though it is now cultivated globally for its medicinal and aromatic properties.
| Outcome / Goal | Effect* | Consistency** | Evidence quality | Trials*** | Notes (population, duration, dose) |
|---|---|---|---|---|---|
| Anxiety Reduction | High | High | 10+ RCTs | 300–600 mg extract significantly lowers anxiety scores [1:3][7:1][2:2] | |
| Sleep Quality | High | Moderate | 5+ RCTs | Improved latency and quality; synergistic with Valerian [2:3] | |
| LDL Cholesterol | Moderate | High | 5 RCTs | Significant reduction in hyperlipidemic/T2D adults over 8+ weeks [3:3][10:1] | |
| Triglycerides | Moderate | High | 5 RCTs | Significant reduction in hyperlipidemic/T2D adults over 8+ weeks [3:4][10:2] | |
| Total Cholesterol | High | High | 5 RCTs | Significant reduction in hyperlipidemic/T2D adults over 8+ weeks [3:5][10:3] | |
| HDL Cholesterol | High | High | 5 RCTs | No significant change observed across clinical trials [3:6] | |
| Systolic Blood Pressure | Moderate | Low | 3 RCTs | Modest reduction (WMD -0.89 to -7.5 mmHg) [12:1][13:1] | |
| HbA1c (in T2D) | Moderate | Moderate | 3 RCTs | Glycemic control and insulin sensitivity improvement [8:2][9:1] | |
| Memory Performance | Moderate | Moderate | 3+ RCTs | Acute improvement in working memory at 300–600 mg [4:2][11:1] | |
| Heart Palpitations | High | Moderate | 1 RCT | Reduced frequency and distress of benign palpitation episodes [14:1] |
Lemon Balm exerts its effects through a multi-target pharmacological profile involving neurotransmitters, metabolic enzymes, and antioxidant pathways.
The primary clinical application for Lemon Balm is neuropsychiatry. It is highly effective for acute anxiolysis, with effects appearing within 60 minutes of ingestion [4:5][7:2]. It uniquely provides a "calm focus" by improving memory and accuracy during stressful cognitive tasks [4:6]. For sleep, it acts as a gentle sedative, reducing nocturnal awakenings and improving overall sleep architecture without causing next-day grogginess [2:4].
Lemon Balm serves as a supportive intervention for dyslipidemia and type 2 diabetes. High-quality meta-analyses show that Lemon Balm can reduce triglycerides, total cholesterol, and LDL cholesterol, though it does not significantly alter HDL-C [3:9]. It also improves glycemic control (fasting glucose and HbA1c), likely mediated by PPAR activation and potent antioxidant properties that reduce systemic oxidative stress [8:4][9:2][18].
Beyond blood pressure reduction, Lemon Balm has a stabilizing effect on the heart. It significantly reduces the subjective frequency and psychiatric distress associated with benign palpitations [14:2]. It also exhibits mild cardioprotective properties by lowering systemic inflammatory markers and SBP [12:2][13:2][19].
Studies on body weight and composition are primarily limited to animal models (such as high-fat diet rodent models), where Lemon Balm extracts limit weight gain and fat accumulation by activating PPAR pathways and reducing lipogenesis. However, human clinical trials have not demonstrated significant weight loss or fat mass reductions. Its metabolic benefits appear to be localized to glycemic control and lipid profiles rather than direct body composition modification [3:10][2:5].
In traditional and modern integrative medicine, Lemon Balm is used for its antispasmodic properties in the gastrointestinal tract. It is often utilized to manage functional dyspepsia, irritable bowel syndrome, and infantile colic, although large-scale adult meta-analyses in this domain are sparse compared to neuropsychiatric data [5:4].
CLINICAL PROTOCOL SUMMARY
- For Acute Stress/Cognition: 300–600 mg of standardized extract (with breakfast).
- For Insomnia/Restlessness: 600 mg of extract 45 minutes before sleep.
- For Lipids/Glycemia: 1,000 mg of extract (or 3,000 mg powder) split into two doses with lunch and dinner.
Lemon Balm is Generally Recognized As Safe (GRAS) by the FDA and has a very high safety profile.
THYROID CONTRAINDICATION
Lemon Balm may inhibit TSH receptor binding and reduce thyroid hormone levels. Individuals with hypothyroidism or those taking levothyroxine should avoid high-dose extracts.
For acute anxiety and stress, effects are typically felt within 60–90 minutes. For metabolic benefits (lipids and glucose), consistent supplementation for 8–12 weeks is required to see significant changes in blood biomarkers.
At doses of 300–600 mg, it typically does not cause daytime grogginess and can improve cognitive performance. However, doses exceeding 900 mg are more sedative and may result in temporary sluggishness.
Yes. Clinical trials have safely used Lemon Balm daily for up to 4 months. There is no strong evidence of physical dependency or withdrawal, though periodic "cycling" (e.g., 5 days on, 2 days off) is often practiced to maintain sensitivity to its calming effects.
Yes. Unlike some other herbs (e.g., Kava), Lemon Balm has a clean safety profile regarding the liver and is not linked to hepatotoxicity according to the NIH LiverTox database [15:3].
Yes, but primarily when used topically as a 1% cream. Oral supplementation is not the primary route for treating herpes simplex outbreaks.
Evidence for Lemon Balm was evaluated by prioritizing:
Evidence grading follows the GRADE framework:
Ghazizadeh J, et al. (2021). The effects of lemon balm (Melissa officinalis L.) on depression and anxiety in clinical trials: A systematic review and meta-analysis. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/34449930/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Cases J, et al. (2011). Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Mediterranean Journal of Nutrition and Metabolism. https://pmc.ncbi.nlm.nih.gov/articles/PMC3230760/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Shahsavari K, et al. (2024). Effects of Melissa officinalis (lemon balm) consumption on serum lipid profile: a meta-analysis of randomized controlled trials. BMC Complementary Medicine and Therapies. https://pubmed.ncbi.nlm.nih.gov/38575930/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Kennedy DO, et al. (2003). Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm). Neuropsychopharmacology. https://pubmed.ncbi.nlm.nih.gov/12888775/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Shakeri A, et al. (2016). Melissa officinalis L. - A review of its traditional uses, phytochemistry and pharmacology. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/27167460/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Awad R, et al. (2009). Bioassay-guided fractionation of lemon balm using an in vitro measure of GABA transaminase activity. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/19165747/ ↩︎ ↩︎ ↩︎
Kennedy DO, et al. (2004). Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis. Psychosomatic Medicine. https://pubmed.ncbi.nlm.nih.gov/15272110/ ↩︎ ↩︎ ↩︎
Asadi A, et al. (2019). The effects of a Melissa officinalis L. based product on metabolic parameters in patients with type 2 diabetes mellitus: A randomized double-blinded controlled clinical trial. Complementary Therapies in Medicine. https://pubmed.ncbi.nlm.nih.gov/30681971/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Haybar H, et al. (2018). Efficacy of Melissa officinalis L. (lemon balm) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/30548118/ ↩︎ ↩︎ ↩︎
Jandaghi P, et al. (2016). Lemon balm: A promising herbal therapy for patients with borderline hyperlipidemia. Complementary Therapies in Medicine. https://pubmed.ncbi.nlm.nih.gov/27261994/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Scholey A, et al. (2014). Anti-stress effects of lemon balm-containing foods. Nutrients. https://pubmed.ncbi.nlm.nih.gov/25360512/ ↩︎ ↩︎ ↩︎
Heshmati J, et al. (2020). Effects of Melissa officinalis (Lemon Balm) on cardio-metabolic outcomes: A systematic review and meta-analysis. Phytotherapy Research. https://doi.org/10.1002/ptr.6744 ↩︎ ↩︎ ↩︎ ↩︎
Pooled Analysis (2021). Effects of Melissa officinalis L. (Lemon Balm) Extract Supplementation on Cardiovascular Risk Factors: A Pooled Analysis of Randomized Controlled Trials. Journal of Food and Nutrition Research. https://doi.org/10.12691/jfnr-9-7-5 ↩︎ ↩︎ ↩︎
Alijaniha F, et al. (2015). Heart palpitation relief with Melissa officinalis leaf extract: double blind, randomized, placebo controlled trial. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/25680840/ ↩︎ ↩︎ ↩︎
LiverTox (2024). Lemon Balm. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.ncbi.nlm.nih.gov/books/NBK600583/ ↩︎ ↩︎ ↩︎ ↩︎
Yoo DY, et al. (2011). Effects of Melissa officinalis L. extract on neurogenesis associated with serum corticosterone and GABA. Neurochemical Research. https://pubmed.ncbi.nlm.nih.gov/21076869/ ↩︎
Noguchi-Shinohara M, et al. (2015). Pharmacokinetics, Safety and Tolerability of Melissa officinalis Extract which Contained Rosmarinic Acid. PLOS ONE. https://doi.org/10.1371/journal.pone.0126422 ↩︎ ↩︎ ↩︎
Miraj S, et al. (2017). Melissa officinalis L: A Review Study With an Antioxidant Prospective. Journal of Evidence-Based Complementary & Alternative Medicine. https://pubmed.ncbi.nlm.nih.gov/27620926/ ↩︎
Petrisor G, et al. (2022). Melissa officinalis: Composition, Pharmacological Effects and Derived Release Systems-A Review. International Journal of Molecular Sciences. https://pubmed.ncbi.nlm.nih.gov/35408950/ ↩︎
LactMed (2024). Lemon Balm. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK501841/ ↩︎